Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer

Clinical trial NCT03370367 · COMPLETED

Trial details

NCT number: NCT03370367
Sponsor: Eastern Cooperative Oncology Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Stage I-II Head and Neck Cancer

Start date: 1989-05-15
Primary completion: 1999-01-15
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.